Health and Human Services Department, Food and Drug Administration
The Food and Drug Administration is correcting a proposed rule that appeared in the Federal Register of March 5, 2003 (68 FR 10417). The document reopened for 30 days the comment period for a proposed rule entitled "Dietary Supplements Containing Ephedrine Alkaloids" (June 4, 1997, 62 FR 30678). The former document was published with an inadvertent error. This document corrects that error.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration 21 CFR Part 111 [Docket No. 95N-0304] RIN 0910-AC51 AGENCY: Food and Drug Administration, HHS. ACTION: Proposed rule; correction. SUMMARY: The Food and Drug Administration is correcting a proposed rule that appeared in the Federal Register of March 5, 2003 ( 68 FR 10417 ). The document reopened for 30 days the comment period for a proposed rule entitled “Dietary Supplements Containing Ephedrine Alkaloids” (June 4, 1997, 62 FR 30678 ). The former document was published with an inadvertent error. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy and Planning (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010. SUPPLEMENTARY INFORMATION: In FR Doc. 03-5072 , appearing on page 10417 in the Federal Register of Wednesday, March 5, 2003, the following correction is made: 1. On page 10420, in the second column, reference 7 is corrected to read: 7. Shekelle, P., S. Morton, M. Maglione, et al., “Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects,” Evidence Report/Technology Assessment No. 76 (Prepared by Southern California Evidence-based Practice Center, RAND, under Contract No. 290-97-0001, Task Order No. 9), Agency for Healthcare Research and Quality, February 2003, Publication No. 03-E022, Rockville, MD. Dated: March 17, 2003. William K. Hubbar…
Other Federal Register documents from the same docket.
Dietary Supplements Containing Ephedrine Alkaloids; Reopening of the Comment Period
Dietary Supplements Containing Ephedrine Alkaloids; Administrative Docket Update; Availability
Dietary Supplements Containing Ephedrine Alkaloids; Withdrawal in Part
Dietary Supplements Containing Ephedrine Alkaloids; Reopening of Comment Period
Dietary Supplements Containing Ephedrine Alkaloids; Notification of Intent to Reopen Comment Period
Citation: 68 FR 14360
